PLoS ONE (Jan 2023)

Postoperative opioid prescribing patients with diabetes: Opportunities for personalized pain management.

  • Alban Zammit,
  • Jean Coquet,
  • Jennifer Hah,
  • Oualid El Hajouji,
  • Steven M Asch,
  • Ian Carroll,
  • Catherine M Curtin,
  • Tina Hernandez-Boussard

DOI
https://doi.org/10.1371/journal.pone.0287697
Journal volume & issue
Vol. 18, no. 8
p. e0287697

Abstract

Read online

BackgroundOpioids are commonly prescribed for postoperative pain, but may lead to prolonged use and addiction. Diabetes impairs nerve function, complicates pain management, and makes opioid prescribing particularly challenging.MethodsThis retrospective observational study included a cohort of postoperative patients from a multisite academic health system to assess the relationship between diabetes, pain, and prolonged opioid use (POU), 2008-2019. POU was defined as a new opioid prescription 3-6 months after discharge. The odds that a patient had POU was assessed using multivariate logistic regression controlling for patient factors (e.g., demographic and clinical factors, as well as prior pain and opiate use).FindingsA total of 43,654 patients were included, 12.4% with diabetes. Patients with diabetes had higher preoperative pain scores (2.1 vs 1.9, pInterpretationIn conclusion, surgical patients with diabetes are at increased risk for POU even after controlling for likely covariates, yet they receive similar postoperative opiate therapy. The results suggest a more tailored approach to diabetic postoperative pain management is warranted.